Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Compare plans for Claude Code in this pricing and features breakdown. Discover which plan fits your needs and budget, this in ...

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

For our series Making of a Poem, we’re asking poets and translators to dissect the poems they’ve published in our pages.

The cryptocurrency space has seen a wave of momentum around Hyperliquid, as its native token HYPE continues to surge in value ...

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

AWS has launched Kiro, a spec-driven, agentic AI IDE based on Visual Studio Code. It joins a growing lineup of VS Code forks ...

Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies in an $888M deal. The merger boosts HYPE token’s market momentum.